The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Antimicrobial Susceptibility Testing Market Insights and Sales Trends 2025

Antimicrobial Susceptibility Testing Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1832462

No of Pages : 110

Synopsis

The global Antimicrobial Susceptibility Testing market size is expected to reach US$ 1848.8 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Antimicrobial Susceptibility Testing in various end use industries. The expanding demands from the Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Other Applications, are propelling Antimicrobial Susceptibility Testing market. Antibacterial Susceptibility Testing, one of the segments analysed

in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antifungal Susceptibility Testing segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.

Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antimicrobial Susceptibility Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Antimicrobial Susceptibility Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Antimicrobial Susceptibility Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antimicrobial Susceptibility Testing sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Antimicrobial Susceptibility Testing covered in this report include Biomérieux, Danaher, BD, Thermo Fisher, Bio-Rad, Hi-Media, Merlin, Liofilchem and Accelerate Diagnostics, etc.

The global Antimicrobial Susceptibility Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Biomérieux
  • Danaher
  • BD
  • Thermo Fisher
  • Bio-Rad
  • Hi-Media
  • Merlin
  • Liofilchem
  • Accelerate Diagnostics
  • Alifax
  • Creative Diagnostics
  • Merck Group
  • Synbiosis
  • Bioanalyse
  • Zhuhai Dl Biotech

Global Antimicrobial Susceptibility Testing market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Antimicrobial Susceptibility Testing market, Segment by Type:

  • Antibacterial Susceptibility Testing
  • Antifungal Susceptibility Testing
  • Antiparasitic Susceptibility Testing
  • Other Susceptibility Testing

Global Antimicrobial Susceptibility Testing market, by Application

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Epidemiology
  • Other Applications

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antimicrobial Susceptibility Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Antimicrobial Susceptibility Testing
1.1 Antimicrobial Susceptibility Testing Market Overview
1.1.1 Antimicrobial Susceptibility Testing Product Scope
1.1.2 Antimicrobial Susceptibility Testing Market Status and Outlook
1.2 Global Antimicrobial Susceptibility Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Antimicrobial Susceptibility Testing Market Size by Region (2018-2029)
1.4 Global Antimicrobial Susceptibility Testing Historic Market Size by Region (2018-2023)
1.5 Global Antimicrobial Susceptibility Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Antimicrobial Susceptibility Testing Market Size (2018-2029)
1.6.1 North America Antimicrobial Susceptibility Testing Market Size (2018-2029)
1.6.2 Europe Antimicrobial Susceptibility Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Antimicrobial Susceptibility Testing Market Size (2018-2029)
1.6.4 Latin America Antimicrobial Susceptibility Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Antimicrobial Susceptibility Testing Market Size (2018-2029)
2 Antimicrobial Susceptibility Testing Market by Type
2.1 Introduction
2.1.1 Antibacterial Susceptibility Testing
2.1.2 Antifungal Susceptibility Testing
2.1.3 Antiparasitic Susceptibility Testing
2.1.4 Other Susceptibility Testing
2.2 Global Antimicrobial Susceptibility Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Antimicrobial Susceptibility Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Antimicrobial Susceptibility Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Antimicrobial Susceptibility Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Antimicrobial Susceptibility Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Antimicrobial Susceptibility Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Antimicrobial Susceptibility Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Antimicrobial Susceptibility Testing Revenue Breakdown by Type (2018-2029)
3 Antimicrobial Susceptibility Testing Market Overview by Application
3.1 Introduction
3.1.1 Clinical Diagnostics
3.1.2 Drug Discovery and Development
3.1.3 Epidemiology
3.1.4 Other Applications
3.2 Global Antimicrobial Susceptibility Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Antimicrobial Susceptibility Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Antimicrobial Susceptibility Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Antimicrobial Susceptibility Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Antimicrobial Susceptibility Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Antimicrobial Susceptibility Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Antimicrobial Susceptibility Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Antimicrobial Susceptibility Testing Revenue Breakdown by Application (2018-2029)
4 Antimicrobial Susceptibility Testing Competition Analysis by Players
4.1 Global Antimicrobial Susceptibility Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Susceptibility Testing as of 2022)
4.3 Date of Key Players Enter into Antimicrobial Susceptibility Testing Market
4.4 Global Top Players Antimicrobial Susceptibility Testing Headquarters and Area Served
4.5 Key Players Antimicrobial Susceptibility Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Antimicrobial Susceptibility Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biomérieux
5.1.1 Biomérieux Profile
5.1.2 Biomérieux Main Business
5.1.3 Biomérieux Antimicrobial Susceptibility Testing Products, Services and Solutions
5.1.4 Biomérieux Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Biomérieux Recent Developments
5.2 Danaher
5.2.1 Danaher Profile
5.2.2 Danaher Main Business
5.2.3 Danaher Antimicrobial Susceptibility Testing Products, Services and Solutions
5.2.4 Danaher Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Danaher Recent Developments
5.3 BD
5.3.1 BD Profile
5.3.2 BD Main Business
5.3.3 BD Antimicrobial Susceptibility Testing Products, Services and Solutions
5.3.4 BD Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Recent Developments
5.4 Thermo Fisher
5.4.1 Thermo Fisher Profile
5.4.2 Thermo Fisher Main Business
5.4.3 Thermo Fisher Antimicrobial Susceptibility Testing Products, Services and Solutions
5.4.4 Thermo Fisher Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Recent Developments
5.5 Bio-Rad
5.5.1 Bio-Rad Profile
5.5.2 Bio-Rad Main Business
5.5.3 Bio-Rad Antimicrobial Susceptibility Testing Products, Services and Solutions
5.5.4 Bio-Rad Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Recent Developments
5.6 Hi-Media
5.6.1 Hi-Media Profile
5.6.2 Hi-Media Main Business
5.6.3 Hi-Media Antimicrobial Susceptibility Testing Products, Services and Solutions
5.6.4 Hi-Media Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Hi-Media Recent Developments
5.7 Merlin
5.7.1 Merlin Profile
5.7.2 Merlin Main Business
5.7.3 Merlin Antimicrobial Susceptibility Testing Products, Services and Solutions
5.7.4 Merlin Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Merlin Recent Developments
5.8 Liofilchem
5.8.1 Liofilchem Profile
5.8.2 Liofilchem Main Business
5.8.3 Liofilchem Antimicrobial Susceptibility Testing Products, Services and Solutions
5.8.4 Liofilchem Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Liofilchem Recent Developments
5.9 Accelerate Diagnostics
5.9.1 Accelerate Diagnostics Profile
5.9.2 Accelerate Diagnostics Main Business
5.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
5.9.4 Accelerate Diagnostics Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Accelerate Diagnostics Recent Developments
5.10 Alifax
5.10.1 Alifax Profile
5.10.2 Alifax Main Business
5.10.3 Alifax Antimicrobial Susceptibility Testing Products, Services and Solutions
5.10.4 Alifax Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Alifax Recent Developments
5.11 Creative Diagnostics
5.11.1 Creative Diagnostics Profile
5.11.2 Creative Diagnostics Main Business
5.11.3 Creative Diagnostics Antimicrobial Susceptibility Testing Products, Services and Solutions
5.11.4 Creative Diagnostics Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Creative Diagnostics Recent Developments
5.12 Merck Group
5.12.1 Merck Group Profile
5.12.2 Merck Group Main Business
5.12.3 Merck Group Antimicrobial Susceptibility Testing Products, Services and Solutions
5.12.4 Merck Group Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Merck Group Recent Developments
5.13 Synbiosis
5.13.1 Synbiosis Profile
5.13.2 Synbiosis Main Business
5.13.3 Synbiosis Antimicrobial Susceptibility Testing Products, Services and Solutions
5.13.4 Synbiosis Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Synbiosis Recent Developments
5.14 Bioanalyse
5.14.1 Bioanalyse Profile
5.14.2 Bioanalyse Main Business
5.14.3 Bioanalyse Antimicrobial Susceptibility Testing Products, Services and Solutions
5.14.4 Bioanalyse Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Bioanalyse Recent Developments
5.15 Zhuhai Dl Biotech
5.15.1 Zhuhai Dl Biotech Profile
5.15.2 Zhuhai Dl Biotech Main Business
5.15.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Products, Services and Solutions
5.15.4 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Revenue (US$ Million) & (2018-2023)
5.15.5 Zhuhai Dl Biotech Recent Developments
6 North America
6.1 North America Antimicrobial Susceptibility Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Antimicrobial Susceptibility Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antimicrobial Susceptibility Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antimicrobial Susceptibility Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antimicrobial Susceptibility Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antimicrobial Susceptibility Testing Market Dynamics
11.1 Antimicrobial Susceptibility Testing Industry Trends
11.2 Antimicrobial Susceptibility Testing Market Drivers
11.3 Antimicrobial Susceptibility Testing Market Challenges
11.4 Antimicrobial Susceptibility Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’